Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pregabalin as add-on therapy for pediatric and adult generalized tonic-clonic seizures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Generalized Tonic Clonic Seizures | Phase 3 | Status: COMPLETED | Results posted: 2019-08-28